Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
213.3 USD | -1.82% | -3.80% | -9.87% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.87% | 11.19B | |
+51.94% | 63.85B | |
-2.30% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.18% | 26.52B | |
-21.53% | 18.69B | |
+2.83% | 12.73B | |
+22.35% | 12.11B | |
+27.57% | 12.07B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Charles River Laboratories International Q1 Non-GAAP Earnings Rise, Revenue Fall; Maintains Full Year 2024 Earnings Guidance